Skip to main content

4 Result(s)

within T Aurran-Schleinitz Remove this filter

and

  1. Article

    Open Access

    Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial

    Efficacy of lenalidomide was investigated in 103 patients with relapsed/refractory chronic lymphocytic leukemia (CLL) treated on the prospective, multicenter randomized phase-II CLL-009 trial. Interphase cytog...

    A Bühler, C-M Wendtner, T J Kipps, L Rassenti, G A M Fraser… in Blood Cancer Journal (2016)

    Download PDF (370 KB) View Article

  2. No Access

    Article

    Identification of a new monoclonal B-cell subset in unaffected first-degree relatives in familial chronic lymphocytic leukemia

    T Aurran-Schleinitz, W Telford, S Perfetto, N Caporaso, W Wilson… in Leukemia (2005)

  3. No Access

    Article

    SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor

    The FLT3 receptor tyrosine kinase and its ligand, FL, regulate the development of hematopoietic stem cells and early B lymphoid progenitors. FL has a strong capacity to boost production of dendritic and natura...

    S Marchetto, E Fournier, N Beslu, T Aurran-Schleinitz, P Dubreuil, J-P Borg… in Leukemia (1999)

  4. No Access

    Article

    Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD

    F Viret, C Chabannon, T Aurran-Schleinitz, D Reviron… in Bone Marrow Transplantation (1999)